These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
620 related articles for article (PubMed ID: 24188201)
21. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694 [TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress. Martín A; Pérez-Girón JV; Hernanz R; Palacios R; Briones AM; Fortuño A; Zalba G; Salaices M; Alonso MJ J Hypertens; 2012 Feb; 30(2):315-26. PubMed ID: 22179086 [TBL] [Abstract][Full Text] [Related]
23. 15-deoxy-Delta12,14 prostaglandin GJ2 but not rosiglitazone regulates metalloproteinase 9, NOS-2, and cyclooxygenase 2 expression and functions by peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms in cardiac cells. Hovsepian E; Penas F; Goren NB Shock; 2010 Jul; 34(1):60-7. PubMed ID: 19997048 [TBL] [Abstract][Full Text] [Related]
24. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846 [TBL] [Abstract][Full Text] [Related]
25. IL-8 production in response to cigarette smoke is decreased in epithelial cells from COPD patients. Nadigel J; Audusseau S; Baglole CJ; Eidelman DH; Hamid Q Pulm Pharmacol Ther; 2013 Oct; 26(5):596-602. PubMed ID: 23499888 [TBL] [Abstract][Full Text] [Related]
26. PPARγ agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4/TRIF/IRF3/IP-10 signaling pathway. Ji Y; Liu J; Wang Z; Li Z Cytokine; 2011 Sep; 55(3):409-19. PubMed ID: 21700474 [TBL] [Abstract][Full Text] [Related]
27. PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway. Ji Y; Liu J; Wang Z; Liu N; Gou W Lab Invest; 2009 Aug; 89(8):887-902. PubMed ID: 19451898 [TBL] [Abstract][Full Text] [Related]
28. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2. Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232 [TBL] [Abstract][Full Text] [Related]
29. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Sommer M; Wolf G Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750 [TBL] [Abstract][Full Text] [Related]
30. Endoplasmic reticulum chaperone GRP78 mediates cigarette smoke-induced necroptosis and injury in bronchial epithelium. Wang Y; Zhou JS; Xu XC; Li ZY; Chen HP; Ying SM; Li W; Shen HH; Chen ZH Int J Chron Obstruct Pulmon Dis; 2018; 13():571-581. PubMed ID: 29445274 [TBL] [Abstract][Full Text] [Related]
31. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium. Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081 [TBL] [Abstract][Full Text] [Related]
32. Activating transcription factor 3 represses cigarette smoke-induced IL6 and IL8 expression via suppressing NF-κB activation. Wu YP; Cao C; Wu YF; Li M; Lai TW; Zhu C; Wang Y; Ying SM; Chen ZH; Shen HH; Li W Toxicol Lett; 2017 Mar; 270():17-24. PubMed ID: 28185985 [TBL] [Abstract][Full Text] [Related]
33. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy. Xiao J; Leung JC; Chan LY; Tang SC; Lai KN Clin Immunol; 2009 Aug; 132(2):266-76. PubMed ID: 19443277 [TBL] [Abstract][Full Text] [Related]
34. Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists. Chistyakov DV; Aleshin SE; Astakhova AA; Sergeeva MG; Reiser G J Neurochem; 2015 Jul; 134(1):113-24. PubMed ID: 25818681 [TBL] [Abstract][Full Text] [Related]
35. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma). Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751 [TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of rosiglitazone on lipopolysaccharide-induced inflammation in a murine model and HK-2 cells. Wang WM; Chen H; Zhong F; Lu Y; Han L; Chen N Am J Nephrol; 2011; 34(2):152-62. PubMed ID: 21734368 [TBL] [Abstract][Full Text] [Related]
37. [Expression of toll-like receptor 4 in human alveolar epithelial cells and its role in cellular inflammation]. Zhou M; Wan HY; Huang SG; Li B; Li M Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2112-6. PubMed ID: 19080471 [TBL] [Abstract][Full Text] [Related]
38. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation. Kim KY; Ahn JH; Cheon HG Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976 [TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Sánchez-Hidalgo M; Martín AR; Villegas I; Alarcón De La Lastra C Biochem Pharmacol; 2005 Jun; 69(12):1733-44. PubMed ID: 15876425 [TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1. Gao M; Hu Z; Zheng Y; Zeng Y; Shen X; Zhong D; He F Shock; 2011 Sep; 36(3):228-34. PubMed ID: 21617575 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]